Published in Clin Exp Immunol on May 01, 1968
Diagnosis of penicillin allergy by skin testing: the Manitoba experience. Can Med Assoc J (1978) 1.33
Tests for penicillin allergy in man. II. The immunological cross-reaction between penicillins and cephalosporins. Immunology (1974) 0.98
Mouse anti-benzylpenicilloyl IgE monoclonal antibody: preparation, characterization and cross-reactivity. Clin Exp Immunol (1987) 0.75
The structure of cephalesporin C. Biochem J (1961) 7.21
LABORATORY AND CLINICAL EVALUATION OF A NEW ANTIBIOTIC--CEPHALOTHIN. Ann Intern Med (1965) 2.88
PLATELET AND LEUKOCYTE ISOANTIGENS AND THEIR ANTIBODIES: SEROLOGIC PHYSIOLOGIC AND CLINICAL STUDIES. Prog Hematol (1964) 2.47
Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med (1966) 2.33
Positive direct Coombs tests due to cephalothin. N Engl J Med (1967) 2.26
Cephalothin in serious bacterial infection. Ann Intern Med (1966) 2.25
SOME EXPERIMENTAL AND CLINICAL STUDIES ON CEPHALOTHIN. Clin Pharmacol Ther (1964) 1.95
CEPHALOTHIN--A NEW ANTIBIOTIC. PRELIMINARY CLINICAL AND LABORATORY STUDIES. JAMA (1964) 1.83
Coombs' positive reactions associated with sodium cephalothin therapy. JAMA (1967) 1.52
Immunohemolytic anemia due to antipenicillin antibodies. Report of a case. N Engl J Med (1966) 1.26
Benzylpenicilloyl specific serum antibodies to penicillin in man. I. Development of a sensitive hemagglutination assay method and haptenic specificities of antibodies. J Immunol (1966) 1.26
Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy. N Engl J Med (1966) 1.23
The immunogenicity of cephalosporin derivatives and their cross-reaction with penicillin. Immunology (1966) 1.16
Studies on the epidemiology of adverse drug reactions. IV. The relationship of cephalothin and penicillin allergy. JAMA (1966) 1.12
TREATMENT OF INFECTIONS IN MAN WITH CEPHALOTHIN. JAMA (1964) 1.10
Drug-induced hemolysis. Annu Rev Med (1967) 1.06
Immunochemical mechanisms of penicillin induced Coombs positivity and hemolytic anemia in man. Int Arch Allergy Appl Immunol (1967) 1.03
ANAPHYLACTOID REACTION TO AN INITIAL DOSE OF SODIUM CEPHALOTHIN. JAMA (1965) 1.02
COMMON ANTIGENIC DETERMINANTS OF PENICILLIN G, CEPHALOTHIN AND 6-AMINOPENICILLANIC ACID IN RABBITS. J Immunol (1965) 0.93
Cross-allergenicity of penicillin G and related substances. Lancet (1962) 0.92
Immunological cross-reactivities of cephalothin and its related compounds with benzylpenicillin (penicillin G). Nature (1966) 0.86
Anaphylaxis to cephaloridine in a nurse who prepared solutions of the drug. JAMA (1967) 0.81
Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science (1968) 7.70
Chromic chloride: a coupling reagent for passive hemagglutination reactions. J Immunol (1967) 7.30
Serum levels of immune globulins in health and disease: a survey. Pediatrics (1966) 6.10
The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest (1972) 4.80
Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest (1973) 4.69
Receptor sites of human monocytes for IgG. Int Arch Allergy Appl Immunol (1968) 4.07
Isolation of normal T cells in chronic lymphatic leukaemia. Lancet (1973) 3.95
Evidence for control of synthesis of the varible regions of the heavy chains of immunoglobulins G and M by the same gene. Proc Natl Acad Sci U S A (1970) 2.96
Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci U S A (1970) 2.89
A new rapid method for genetic typing of human immunoglobulins. J Immunol (1968) 2.61
The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res (1993) 2.54
Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J Immunol (1986) 2.53
The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46
Anaphylactoid transfusion reactions associated with anti-IgA. Lancet (1968) 2.40
Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med (1966) 2.33
A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase. Biochem Biophys Res Commun (1978) 2.30
Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease. Science (1971) 2.27
Peyer's patches: morphologic studies. Cell Immunol (1970) 2.08
Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol (1969) 2.05
Anti-M causing delayed hemolytic transfusion reaction. Transfusion (1983) 2.04
Characterization of the Fc receptor for IgG on a human macrophage cell line, U937. J Immunol (1980) 2.03
Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med (1973) 2.02
The incidence and antigenic specificity of antibodies against denatured human collagen in rheumatoid arthritis. Clin Immunol Immunopathol (1974) 1.94
Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science (1986) 1.91
Immunohistological and elution studies of the human placenta. J Exp Med (1971) 1.88
Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol (1999) 1.87
A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83
Identification of a second class of IgG Fc receptors on human neutrophils. A 40 kilodalton molecule also found on eosinophils. J Exp Med (1986) 1.82
The interaction of monocytes and macrophages with immunoglobulins and complement. Ser Haematol (1970) 1.82
Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. J Clin Invest (1985) 1.82
The occurrence of antibodies to collagen in synovial fluids. Clin Immunol Immunopathol (1975) 1.74
"Sandwich" solid phase radioimmunoassay for the quantitative deterimination of human immunoglobulins. J Immunol (1969) 1.74
Characterization of an IgA rheumatoid factor: finding properties and reactivity with the subclasses of human G globulin. Immunochemistry (1972) 1.73
Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides. Lancet (1979) 1.67
Rosette formation, a test for cellular immunity. Trans Assoc Am Physicians (1971) 1.64
Proteolytic processing of histone H3 in chromatin: a physiologically regulated event in Tetrahymena micronuclei. Cell (1980) 1.62
Structural studies of human gamma-G-myeloma proteins of different antigenic subgroups and genetic specificities. J Exp Med (1966) 1.62
Macroglobulinemia: an analysis for forty patients. Blood (1972) 1.61
Anionic sites on the membrane intercalated particles of human erythrocyte ghost membranes. Freeze-etch localization. Exp Cell Res (1973) 1.58
The identity of light chains of monoclonal IgG and monoclonal IgM in one patient. Immunochemistry (1969) 1.58
Inhibition of capillary migration by antigen-antibody complexes. J Immunol (1969) 1.55
Impaired renal acidification in patients with hypergammaglobulinemia. Medicine (Baltimore) (1967) 1.55
Granulocytopathies: pleomorphism of neutrophil dysfunction. Am J Med (1969) 1.54
Serum and cerebral spinal fluid complement and serum autoantibodies in systemic lupus erythematosus. Medicine (Baltimore) (1971) 1.52
Thymus-derived rosette-forming cells. N Engl J Med (1973) 1.50
The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50
Clinical, serologic and leukocyte function studies on patients with idiopathic "acquired" agammaglobulinemia and their families. Am J Med (1970) 1.50
A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44
Selective absence of IgA: a family study. J Lab Clin Med (1968) 1.43
Induction and suppression of immunoglobulin synthesis in cultures of human lymphocytes: effects of pokeweed mitogen and Staphylococcus aureus Cowan I. J Immunol (1980) 1.42
A comprehensive transfusion medicine curriculum for medical students. Transfusion Medicine Academic Award Group. Transfusion (1995) 1.42
Factors affecting the labor efficiency of hospital-based blood bank laboratories. Transfusion (1994) 1.39
Clinical and immunologic features of dysgammaglobulinemia type I. Report of a case diagnosed in the first year of life. Am J Med (1966) 1.39
Immunofixation after electrofocusing: improved method for specific detection of serum proteins with determination of isoelectric points. I. Immunofixation print technique for detection of alpha-1-protease inhibitor. J Immunol Methods (1977) 1.39
Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med (1970) 1.39
Discussion paper: cross-reactivity of primate immunoglobulins. Ann N Y Acad Sci (1969) 1.38
Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease production. J Exp Med (1972) 1.37
A new serum factor in normal rabbits. I. Identification and characterization. J Immunol (1965) 1.37
Genetically determined immune deficiency as the predisposing cause of "autoimmunity" and lymphoid neoplasia. Am J Med (1971) 1.36
Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res (1989) 1.36
Studies on the immune response to a characterized antigenic determinant of the tobacco mosaic virus protein. J Exp Med (1970) 1.34
Chemical differences of adult, fetal and hypogammaglobulinemic IgG immunoglobulins. Immunochemistry (1970) 1.34
In vitro development of plasma cells from lymphocytes following pokeweed mitogen stimulation: a fine structural study. Exp Cell Res (1969) 1.34
Serologic specificity of hun anti-IgA and its significance in transfusion. Blood (1969) 1.30
RElation of the human antibody response to flagellin to GM genotype. J Immunol (1971) 1.30
Effect of prednisolone on synthesis of DNA and RNA by human lymphocytes in vitro. Nature (1967) 1.29
Classification of primary immunodeficiencies. N Engl J Med (1973) 1.28
Dissociation of responses to phytohaemagglutinin and adult allogeneic lymphocytes in human foetal lymphoid tissues. Nat New Biol (1973) 1.28
Immunologic deficiency, autoimmune disease, and lymphoma: observations, implications, and speculations. Arthritis Rheum (1966) 1.27
Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal. Mol Cell Biochem (1981) 1.27
In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest (1969) 1.26
Peyer's patches: immunologic studies. J Exp Med (1970) 1.26
Localization of idiotypic antigenic determinants in the Fv region of murine myeloma protein MOPC-315. Proc Natl Acad Sci U S A (1973) 1.24
A new reagent (ZZAP) having multiple applications in immunohematology. Am J Clin Pathol (1982) 1.24
Humoral immunity in vaginal candidiasis. Infect Immun (1977) 1.24
Quantitative studies of phytohemagglutinin-induced DNA and RNA synthesis in normal and agammaglobulinemic leukocytes. J Exp Med (1967) 1.23
On the significance of the heterogeneity in molecular size of human serum gamma A-globulins. Immunochemistry (1965) 1.23
Immunoglobulin abnormalities in families of patients with Waldenström's macroglobulinemia. Am J Med (1967) 1.22
Editorial: T-rosette forming cells, cellular immunity and cancer. N Engl J Med (1975) 1.22
Differentiation of human IgM subclasses by the ability to interact with a factor resembling the first component of complement. J Immunol (1969) 1.21
Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies. Blood (1966) 1.20
Passive immune lysis with chromic chloride-treated erythrocytes. J Immunol (1969) 1.20
Further studies on the pathogenesis of rheumatoid joint inflammation. Arthritis Rheum (1966) 1.19
A variable region subclass of heavy chains common to immunoglobulins G, A, and M and characterized by an unblocked amino-terminal residue. Proc Natl Acad Sci U S A (1970) 1.19
Human chorionic gonadotropin: effects of crude and purified preparations on lymphocyte responses to phytohemagglutinin and allogenenic stimulation. J Immunol (1975) 1.19
Disorders of neutrophil function. Defects in the early stages of the phagocytic process. Clin Exp Immunol (1973) 1.18
Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med (1982) 1.18
Unusual disease of pulmonary arteries with dyspnea. Structure-function relationships. Am J Med (1966) 1.18
Drug-induced immune hemolytic anemia. Am J Med (1975) 1.17
The primary structure of a human IgG2 heavy chain: genetic, evolutionary, and functional implications. J Immunol (1980) 1.17
Transfer factor therapy in immune deficiency states. Annu Rev Med (1973) 1.16
Cellular immunity to platelets in idiopathic thrombocytopenic purpura. Blood (1972) 1.16
The immune globulins. Annu Rev Microbiol (1965) 1.15
A genetic defect in "acquired" agammaglobulinemia. Proc Natl Acad Sci U S A (1968) 1.15
Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood (1986) 1.14
Rheumatoid factors and the etiology of rheumatoid arthritis. Ann N Y Acad Sci (1965) 1.13
Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA (1985) 1.13
Human monocyte heterogeneity: interleukin 1 and prostaglandin E2 production by separate subsets. Eur J Immunol (1985) 1.13